Direct T cell–tumour interaction triggers T(H)1 phenotype activation through the modification of the mesenchymal stromal cells transcriptional programme

por Jin, P, Civini, S, Zhao, Y, De Giorgi, V, Ren, J, Sabatino, M, Jin, J, Wang, H, Bedognetti, D, Marincola, F, Stroncek, D
Publicado 2014

IRF-1 responsiveness to IFN-γ predicts different cancer immune phenotypes

por Murtas, D, Maric, D, De Giorgi, V, Reinboth, J, Worschech, A, Fetsch, P, Filie, A, Ascierto, M L, Bedognetti, D, Liu, Q, Uccellini, L, Chouchane, L, Wang, E, Marincola, F M, Tomei, S
Publicado 2013

CXCR3/CCR5 pathways in metastatic melanoma patients treated with adoptive therapy and interleukin-2

por Bedognetti, D, Spivey, T L, Zhao, Y, Uccellini, L, Tomei, S, Dudley, M E, Ascierto, M L, De Giorgi, V, Liu, Q, Delogu, L G, Sommariva, M, Sertoli, M R, Simon, R, Wang, E, Rosenberg, S A, Marincola, F M
Publicado 2013